WebAbout Telara Pharma has 2 current employee profiles, including Co-Founder Alberto Lázaro. Contacts We're working on getting contact data for Telara Pharma Find more contact data in Search! Get started Employee Profiles Number of Employee Profiles 2 Telara Pharma has 2 current employee profiles, including Co-Founder Alberto Lázaro. WebMay 10, 2024 · Telara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the …

Telara Pharma Stock Price, Funding, Valuation, Revenue

WebTelara Pharma – Developing therapeutic solutions for the prevention and treatment of kidney disease and sepsis. We use cookies on our website to give you the most relevant … Acute kidney Injury (AKI) is a syndrome that results in a sudden decrease in kidney … Cilastatin: a potential treatment strategy against COVID-19 that may decrease … Telara Pharma awarded at the 8th IiSGM Research and Innovation Conference … Telara Pharma S.L. is a spin-off company from the Gregorio Marañón Health … Great! Thank you for you message! We will get back to you real soon. With the creation of Telara Pharma to try to bring cilastatin into clinical use, we … Company (referred to as either “the Company”, “We”, “Us” or “Our” in this … Telara Pharma S.L. has been created in Madrid (Spain), acquiring a license … WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … fein means tax

Telara Pharma - Funding, Financials, Valuation & Investors

WebApr 15, 2024 · Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin for the Treatment and Prevention of Acute Kidney Injury [April 15, 2024] Arch Biopartners is a clinical stage company developing new drug candidates for treating organ damage caused by inflammation WebMay 14, 2024 · Business Description Telara Pharma S.L. is a spin-off company from the Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón Universitary … WebMay 11, 2024 · Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the Imipenem antibiotic in the kidney. Until now, the use of cilastatin is limited to the combination in dual formulation with the antibiotic imipenem, and it has not yet been approved as a stand-alone product. feinmess cnpj